Brian Ayers

Brian Ayers

Auto-generated profile, based on publicly available information

Brian Ayers

Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
BABrian Ayers
Brian Ayers
TSTuomas Sandholm
Tuomas Sandholm
IGIgor Gosev
Igor Gosev
SPSunil Prasad
Sunil Prasad
AKArman Kilic
Arman Kilic

26 September 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
EMElaa Mahdi
Elaa Mahdi
NTNicole Toscano
Nicole Toscano
LPLauren Pierson
Lauren Pierson
ENEric Ndikumana
Eric Ndikumana
BABrian Ayers
Brian Ayers
DWDerek Wakeman
Derek Wakeman

24 March 2019 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
BABrian Ayers
Brian Ayers
RSRachel Stahl
Rachel Stahl
KWKatherine Wood
Katherine Wood
WBWendy Bernstein
Wendy Bernstein
IGIgor Gosev
Igor Gosev
DLDanielle Lindenmuth
Danielle Lindenmuth

1 November 2021 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
DLDanielle M. Lindenmuth
Danielle M. Lindenmuth
KCKarin Chase
Karin Chase
CCChristina Cheyne
Christina Cheyne
JWJulie Wyrobek
Julie Wyrobek
MBMilica Bjelic
Milica Bjelic
IGIgor Gosev
Igor Gosev

4 April 2020 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Closed access
BABrian C Ayers
Brian C Ayers
KWKatherine Wood
Katherine Wood
SMScott McNitt
Scott McNitt
IGIlan Goldenberg
Ilan Goldenberg
LCLeway Chen
Leway Chen
IGIgor Gosev
Igor Gosev
OBJECTIVES: History of prior cardiac surgery has traditionally been considered a risk factor for subsequent cardiac procedures. The aim of this study was to investigate the outcomes of patients implanted with a left ventricular assist device via redo sternotomy. METHODS: Prospectively collected data were reviewed for all patients implanted with a continuous-flow left ventricular assist device at a single institution from December 2006 through June 2018. Patients were separated into 2 cohorts: those with a history of prior cardiac surgery (redo sternotomy) and those undergoing primary sternotomy at the time of left ventricular assist device implantation. The primary outcome was overall survival. RESULTS: Of the 321 patients included in the study, 77 (24%) were implanted via redo sternotomy and 244 (76%) via primary sternotomy. The redo sternotomy cohort was generally older (59 ± 10 vs 57 ± 12 years, P = 0.050) and had a higher incidence of ischaemic disease (70% vs 49%, P = 0.002). The Kaplan–Meier survival analysis demonstrated that overall survival was not significantly different between the redo sternotomy and primary sternotomy groups (6-month survival: 86% vs 92%; 5-year survival: 53% vs 51%; log-rank P = 0.590 for overall difference during follow-up). The propensity score analysis consistently showed that redo sternotomy was not significantly associated with mortality risk (hazard ratio 1.19, 95% confidence interval 0.73–1.93; P = 0.488). Redo sternotomy patients were more likely to require rehospitalization during their first year postoperatively (P = 0.020) and spent less time out of the hospital during the first year (P = 0.046). CONCLUSIONS: The redo sternotomy cohort represents a more technically challenging patient population, but overall survival similar to that of primary sternotomy patients can be achieved.

8 January 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
BABrian Ayers
Brian Ayers
MBMilica Bjelic
Milica Bjelic
NKNeil Kumar
Neil Kumar
KWKatherine Wood
Katherine Wood
BBBryan Barrus
Bryan Barrus
IGIgor Gosev
Igor Gosev
Background The utilization of venoarterial extracorporeal membrane oxygenation (VA‐ECMO) as a life‐supporting therapy has increased exponentially over the last decade. As more patients receive and survive ECMO, there are a number of unanswered clinical questions about their long‐term prognosis and organ function including the need for long‐term dialysis. Methods We aimed to utilize over 208 patient‐years of follow‐up data from our large institutional cohort of VA‐ECMO patients to determine the incidence of requiring VA‐ECMO support on the need for renal replacement therapy after discharge (LT‐dialysis). This retrospective review included all adult VA‐ECMO patients at our institution from January 2014 to October 2018 (N = 283). Results Out of the 99 (35%) survivors, 88 (89%) did not require LT‐dialysis of any duration after discharge from the index hospitalization. Patients who required VA‐ECMO for decompensated cardiogenic shock were more likely to need LT‐dialysis (p = .034), and those who required renal replacement therapy during VA‐ECMO (N = 27) also had a higher incidence of LT‐dialysis (33%). Conclusion Overall, these data suggest there is a low incidence of long‐term dialysis dependence among survivors of VA‐ECMO support. Worries about the potential long‐term detrimental effect of VA‐ECMO should not preclude patients from receiving this life‐saving support.